These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25516654)

  • 1. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
    Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
    World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.
    Li Y; Liu B; Yang F; Yu Y; Zeng A; Ye T; Yin W; Xie Y; Fu Z; Zhao C
    Biomed Pharmacother; 2016 Oct; 83():1239-1246. PubMed ID: 27565846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
    Li X; Ran L; Fang W; Wang D
    Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
    Du L; Fei Z; Song S; Wei N
    Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
    Liu N; Tian H; Zhang G; Sun N; Wang S
    Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.
    Hua S; Kong X; Chen B; Zhuang W; Sun Q; Yang W; Liu W; Zhang Y
    Curr Mol Pharmacol; 2018; 11(4):316-325. PubMed ID: 30101722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro.
    Dai HY; Liu L; Qin SK; He XM; Li SY
    Biomed Pharmacother; 2011 Jun; 65(3):137-41. PubMed ID: 21612887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
    He J; Zhang H
    Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
    Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
    Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
    Engel JB; Martens T; Hahne JC; Häusler SF; Krockenberger M; Segerer S; Djakovic A; Meyer S; Dietl J; Wischhusen J; Honig A
    Anticancer Drugs; 2012 Apr; 23(4):426-36. PubMed ID: 22314264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal.
    Chen L; Cao H; Yu C; Feng Y
    Fundam Clin Pharmacol; 2018 Oct; 32(5):548-557. PubMed ID: 29733466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY; Xu YP; Jin W; Lou LG
    Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.
    Yang F; Yu Y; Lei Q; Zeng A; Li Y; Xie Y; Ye T; Wei Y
    Biomed Pharmacother; 2015 Feb; 69():402-8. PubMed ID: 25661389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
    Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.
    Li Y; Zhang D; Yu K; Hu Y; Wu Q; Qian F; Wang Z
    Biol Res; 2018 Apr; 51(1):11. PubMed ID: 29661232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
    Sun X; Lou LG; Sui DH; Wu XH
    Asian Pac J Cancer Prev; 2014; 15(22):9939-43. PubMed ID: 25520132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model.
    Shan L; Bai B; Lv Y; Xie B; Huang X; Zhu H
    Biomed Pharmacother; 2018 Dec; 108():486-491. PubMed ID: 30243080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis.
    Xiao XY; Hao M; Yang XY; Ba Q; Li M; Ni SJ; Wang LS; Du X
    Cancer Lett; 2011 Mar; 302(1):69-75. PubMed ID: 21216524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.